Novartis Corporation v. Ben Venue Laboratories, Inc., and Bedford Laboratories
Court of Appeals for the Federal Circuit
1Opinion of the Court
CLEVENGER, Circuit Judge.
Novartis Corporation (“Novartis”) appeals from the decision of the United States District Court for the District of New Jersey granting the motion of Ben Venue Laboratories, Inc., and Bedford Laboratories (“Ben Venue”) for summary judgment of noninfringement of U.S. Patent No. 4,711,880. Because we conclude that Novartis has not set forth sufficient facts to entitle it to a trial on the merits of its claim, we affirm the district court’s grant of summary judgment.
BACKGROUND
The drug pamidronate disodium (phos-phonic acid (3-amino-l-hydroxypropyli-dene) bis-, disodium…
2Cases cited12 opinions
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Pitney Bowes, Inc. v. Hewlett-Packard Company, Defendant-CrossCourt of Appeals for the Federal Circuit · 1999
- Vivid Technologies, Inc. v. American Science & Engineering, Inc.Court of Appeals for the Federal Circuit · 1999
- Bayer Ag and Bayer Corporation v. Elan Pharmaceutical Research Corporation and Elan Corporation, PlcCourt of Appeals for the Federal Circuit · 2000
7 more not listed; retrieve them via the Exa API.
3Cited by152 opinions
- Invitrogen Corp. (Formerly Known as Life Technologies, Inc.) v. Clontech Laboratories, Inc.Court of Appeals for the Federal Circuit · 2005
- Akzo Nobel Coatings, Inc. v. Dow Chemical CompanyCourt of Appeals for the Federal Circuit · 2016
- Skyline Steel, LLC v. PilePro, LLCDistrict Court, S.D. New York · 2015
- Taurus IP, LLC v. Daimlerchrysler Corp.Court of Appeals for the Federal Circuit · 2013
- Astra Aktiebolag v. Andrx Pharmaceuticals, Inc.District Court, S.D. New York · 2002
147 more not listed; retrieve them via the Exa API.